These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6844733)

  • 1. The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
    Williams PD; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):153-61. PubMed ID: 6844733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
    Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
    Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-GAG in advanced renal cell carcinoma.
    Child JA
    Prog Clin Biol Res; 1982; 100():663-7. PubMed ID: 7145994
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the growth of a murine renal cell carcinoma and its metastatic patterns.
    Williams PD; Pontes EJ; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):345-9. PubMed ID: 7335958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic studies of a transplantable murine renal adenocarcinoma.
    Sufrin G; Murphy GP
    Invest Urol; 1977 Jul; 15(1):9-14. PubMed ID: 68945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental chemotherapy in a transplantable renal adenocarcinoma. I: Effects of some inhibitors of polyamine synthesis.
    Dunzendorfer U; Kleinert E; Whitmore WF
    Urol Int; 1983; 38(3):162-5. PubMed ID: 6408777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
    Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J
    Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.
    Herr HW; Huffman JL; Huryk R; Heston WD; Melamed MR; Whitmore WF
    Cancer Res; 1988 Apr; 48(8):2061-3. PubMed ID: 3349477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
    Murphy GP; Williams PD
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
    [No Abstract]   [Full Text] [Related]  

  • 17. Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.
    Younes E; Haas GP; Visscher D; Pontes JE; Puri RK; Hillman GG
    J Urol; 1995 Feb; 153(2):490-3. PubMed ID: 7815631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
    Yap HY; Blumenschein GR; Schell F; Bodey GP
    Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth characteristics of metastases from experimental renal tumors.
    Müntzing J; Williams PD; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):541-50. PubMed ID: 180575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.